Avalon Pharmaceuticals Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 8 Calls Today's Calls

Call Details Avalon Pharmaceuticals Earnings Conference Call (Q1 2008) Thu, May 8, 2008, 8:30 am Eastern Listen to the archived event audio About Avalon Pharmaceuticals (NasdaqGM:AVRX) Avalon Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics using AvalonRx technology in the United States. The company offers AVN944, a Phase I clinical development product for the treatment of hematologic and solid tumor cancers. It also engages in preclinical programs to develop inhibitors of the Beta-catenin and Aurora pathways, and discovery programs for Survivin and Myc pathway inhibitors. The company has collaborations with Merck & Co., Inc.; MedImmune, Inc.; Medarex, Inc.; ChemDiv, Inc.; and Novartis Institutes for Biomedical Research, Inc. Avalon Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Germantown, Maryland. More Info: Quote | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings